There were 2,338 press releases posted in the last 24 hours and 440,240 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image